管理补充介导的血栓性微血管病变 (以前是非典型的血清性尿素综合征) 的十个技巧:叙事综述
1Nephrology, Dialysis and Transplantation Service, Hospital Las Higueras, Talcahuano, Concepción, Chile. pilarmusalem@gmail.com.
BMC nephrology
|March 28, 2025
概括
补充介导的血栓性微血管病变 (CM-TMA) 是由补充失调引起的罕见血液疾病. C5 抑制剂已经改变了治疗,改善了结果,但需要进一步的研究才能获得最佳的管理.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 补充介导的血栓性微血管病变 (CM-TMA) 是一种严重的,危及生命的疾病.
- 它的特点是微血管病变的血液溶解性贫血症,血小板缺血和器官损伤.
- 由替代补充路径失调引起,通常是由于遗传或自身免疫因素造成的.
研究的目的:
- 审查目前对CM-TMA的理解.
- 突出诊断标准和挑战.
- 讨论最近的治疗进展和未来的研究方向.
主要方法:
- 关于CM-TMA的科学文献的综述.
- 对诊断方法的分析,包括遗传检测.
- 对治疗策略的评估,重点关注C5抑制剂.
主要成果:
- 诊断包括排除其他TMA和识别遗传易感性.
- C5抑制剂代表了与血交换相比的显著治疗进步.
- 感染预防,特别是针对脑膜炎球菌疾病,对于C5抑制剂至关重要.
结论:
- 管理CM-TMA需要个性化,多学科的方法.
- 遗传学和补充生物学方面的进步提高了治疗疗效.
- 进一步的研究对于解决最佳治疗持续时间和长期结果至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Venous Thrombosis IV: Nursing Management
415
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415
Nephrotic Syndrome II : Assessment and Medical Management
409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Nephrotic Syndrome III : Nursing Management
549
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
549


